https://www.indianpharmapost.com/bliss-gvs-pharma-files-suit-for-ipr-infringement-80922021-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-partners-with-libbs-to-launch-generic-formulations-in-brazil-80952021-03-30T00:00:00+05:30always0.9